Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
•Download as PPTX, PDF•
0 likes•26 views
Blood group antibodies different reaction grades test material required for antibody identification procedure antibody screening using 2-3 cell panel antibpdy identification using 11 cell panel immediate spin phase 37 degree c ahg phase check cells interpretation antibody workups enzyme technique
Report
Share
Report
Share
Recommended
An Octogenarian Patient Of Intracapsular Neck Of Femur Fracture With Pre-oper...
Pre-operative Thrombocytopenia
collection and preparation of sdp single donor platelets
Hb, pt inr, platelet counts
apheresis
principle
donation criteria
sdp vs rdp
guidelines for platelet transfusion
etiologies of thrombocytopenia
isolated thrombocytopenia management
first line second line management
A case presentation of Exchange Transfusion in new born infant with Neonatal ...
A case of Exchange Transfusion in new born infant with Neonatal Jaundice and Rh incompatibility
transfusion management
double volume exchange transfusion
follow up at blood centre
antibody screening
direct antiglobulin test
technique
AABB standards
reconstituted whole blood
hyperbilirubinemia
kernicterus
encephalopathy
hematocrit and volume
Hemolytic disease of the fetus and newborn
Antigens which can cross placenta
RH immunoglobulin administration
RhIg
A Case presentation of Massive Transfusion in post LSCS PPH patient
workup at blood centre
components issued
transfusion summary
criteria for massive transfusion
goal of massive transfusion
Indication protocol for massive transfusion for whole blood, prbc, ffp, cryo, platelets
Targets of resuscitation in massive blood loss
Complications of Massive Transfusion
citrate toxicity
lethal triad
case presentation on diagnosis of beta thalassemia major
case history of 9 month old infant
Paediatric Clinical Approach to this case
examination
workup at blood centre
HPLC screening
laboratory findings
screening of father mother
prominent facial features
PBF and bone marrow findings
usg abdomen
xray skull
prbc transfusion therapy in thalassemia major
classification of thalassemia
national burden in india
pathogenesis- anemia skull bone iron overload
world thalassemia day
Troubleshooting in Transfusion transmissible infection TTI laboratory
Checklist of categories for troubleshooting in TTI
Factors affecting Troubleshooting in TTI Lab
controls used in assay testing
Principles and Practices of ELISA and Rapid for TTI Screening
Equipment Management in TTI Laboratory
calibration of equipments used
Documentation and Records in TTI Laboratory
Root Cause Analysis and Process Improvement in TTI Laboratory
External Quality Assessment Scheme and Proficiency Testing
Waste management in transfusion centre
Principle of Troubleshooting in TTI Lab
Case presentation on HEMOTHERAPY IN SHOCK- hypovolemia and hemorrhagic shock
damage control resuscitation
plasma expanders
hemorrhagic shock
hypovolemic shock
transfusion in shock
blood in shock
hemotherapy in shock
massive transfusion
hypotension
crystalloids
colloids
coagulopathy
hypothermia
acidosis
infusion therapy in shock
hemoglobin based oxygen carriers
prbc ffp platelets transfusion in shock
DCR
Case presentation onHeterozygous variant of Hemoglobin E
case presentation on heterozygous hemoglobin E
investigations
HPLC high performance liquid chromatography test
HbA2
fetal hemoglobin values in different variants of hempglobin
hemoglobinopathies
HbS, HbE, HbD
Tissue Banking and Umbilical Cord Blood Banking
Umbilical cord blood vs bone marrow vs peripheral stem cells
indications of stem cell transplant
Regulatory requirements for cord blood banking
Requirements for processing, testing and storage areas for UCB
Air-handling system
Personnel for Cord Blood Bank
Collection of processed UCB component
procedure- in utero ex utero
transportation
processing
freezing
storage
screening tests
quality control
advantages and disadvantages
labelling
tissue collection
live and deceased donors
Recommended
An Octogenarian Patient Of Intracapsular Neck Of Femur Fracture With Pre-oper...
Pre-operative Thrombocytopenia
collection and preparation of sdp single donor platelets
Hb, pt inr, platelet counts
apheresis
principle
donation criteria
sdp vs rdp
guidelines for platelet transfusion
etiologies of thrombocytopenia
isolated thrombocytopenia management
first line second line management
A case presentation of Exchange Transfusion in new born infant with Neonatal ...
A case of Exchange Transfusion in new born infant with Neonatal Jaundice and Rh incompatibility
transfusion management
double volume exchange transfusion
follow up at blood centre
antibody screening
direct antiglobulin test
technique
AABB standards
reconstituted whole blood
hyperbilirubinemia
kernicterus
encephalopathy
hematocrit and volume
Hemolytic disease of the fetus and newborn
Antigens which can cross placenta
RH immunoglobulin administration
RhIg
A Case presentation of Massive Transfusion in post LSCS PPH patient
workup at blood centre
components issued
transfusion summary
criteria for massive transfusion
goal of massive transfusion
Indication protocol for massive transfusion for whole blood, prbc, ffp, cryo, platelets
Targets of resuscitation in massive blood loss
Complications of Massive Transfusion
citrate toxicity
lethal triad
case presentation on diagnosis of beta thalassemia major
case history of 9 month old infant
Paediatric Clinical Approach to this case
examination
workup at blood centre
HPLC screening
laboratory findings
screening of father mother
prominent facial features
PBF and bone marrow findings
usg abdomen
xray skull
prbc transfusion therapy in thalassemia major
classification of thalassemia
national burden in india
pathogenesis- anemia skull bone iron overload
world thalassemia day
Troubleshooting in Transfusion transmissible infection TTI laboratory
Checklist of categories for troubleshooting in TTI
Factors affecting Troubleshooting in TTI Lab
controls used in assay testing
Principles and Practices of ELISA and Rapid for TTI Screening
Equipment Management in TTI Laboratory
calibration of equipments used
Documentation and Records in TTI Laboratory
Root Cause Analysis and Process Improvement in TTI Laboratory
External Quality Assessment Scheme and Proficiency Testing
Waste management in transfusion centre
Principle of Troubleshooting in TTI Lab
Case presentation on HEMOTHERAPY IN SHOCK- hypovolemia and hemorrhagic shock
damage control resuscitation
plasma expanders
hemorrhagic shock
hypovolemic shock
transfusion in shock
blood in shock
hemotherapy in shock
massive transfusion
hypotension
crystalloids
colloids
coagulopathy
hypothermia
acidosis
infusion therapy in shock
hemoglobin based oxygen carriers
prbc ffp platelets transfusion in shock
DCR
Case presentation onHeterozygous variant of Hemoglobin E
case presentation on heterozygous hemoglobin E
investigations
HPLC high performance liquid chromatography test
HbA2
fetal hemoglobin values in different variants of hempglobin
hemoglobinopathies
HbS, HbE, HbD
Tissue Banking and Umbilical Cord Blood Banking
Umbilical cord blood vs bone marrow vs peripheral stem cells
indications of stem cell transplant
Regulatory requirements for cord blood banking
Requirements for processing, testing and storage areas for UCB
Air-handling system
Personnel for Cord Blood Bank
Collection of processed UCB component
procedure- in utero ex utero
transportation
processing
freezing
storage
screening tests
quality control
advantages and disadvantages
labelling
tissue collection
live and deceased donors
Transfusion support in Surgery- elective surgery, cardiac surgery, MSBOS, Tra...
AABB indications
Elective surgeries- Maximum surgical blood ordering schedule
Anemia and surgery- including Transfusion Trigger
Surgery and coagulation disorders- including factor replacement
Transfusion in cardiac surgeries- including autologous transfusion
Patient Blood management in surgery
Allogenic Transfusion
Autologous Transfusion- Intra And Postoperative Red Cell Salvage, Haemodilution
Blood Substitutes
Haematopoietic Factors
Antifibrinolytics
Fibrin Sealants
Conjugated Oestrogens.
AABB pretransfusion testing schemes
Type and screen
Maximum surgical blood ordering schedule
transfusion trigger for surgery
factor replacement in surgery
autologous transfusion
cell salvage
perioperative
massive transfusion protocol
Platelet disorders- qualitative and quantitative
platelets
functions
functional qualitative platelet disorders
quantitative platelet disorders
thrombocytopenia
thrombocytosis
platelet adhesion
aggregation
glanzman thrombesthenia
bernard soulier syndrome
alpha granules
idiopathic thrombocytopenic purpura ITP
Thrombotic thrombocytopenic purpura TTP
Hemolytic uremic syndrome HUS
Neonatal Alloimmune Thrombocytopenia
PSEUDO Thrombocytopenia
vin willebrand factor, disease and Hemophilia
Pathophysiology & Management of-Haemophilia
Von Willebrand Disease
hemostatic pathway
coagulation pathway
hemophilia A
Hemophilia B
parahemophilia
clinical manifestations
treatments
inheritance
laboratory features
prenatal analysis
factor concentrates
eaca
tranexamic acid
DDVAPS- desmopressin agents
vWF gene
classifcation of vWD
Granulocyte antigens & antibodies and their role in transfusion medicinepptx
what are granulocytes?
Granulocyte antigens
neonatal alloimmune neutropenia (NAN)
Transfusion-related acute lung injury (TRALI)
immune neutropenia after HPC transplantation
refractoriness to granulocyte transfusion
chronic benign autoimmune neutropenia of infancy (AIN)
Antigens on FcyRIIIb (CD16b)
Antigens on CD177
Antigens on CTL2
Antigens on CD11a and CD11b
Immune neutrophil disorders
granulocyte agglutination tests
GRANULOCYTE IMMUNOFLUORESCENCE test
HNA typing
Monoclonal-antibody capture assays:
Adsorption and Elution- heal elution ether elution Autoadsorption alloadsorpt...
TYPES- ELUTION
Heat Elution
Ether Elution
Elution using chemical treatment
CDP
ZZAP
ELUTION APPLICATIONS
Autoadsorption
Alloadsorption
Allo-Antibody Adsorption Technique
Cold Auto-Adsorption Technique
Warm Auto-Adsorption Technique
Donath-Landsteiner Technique
Adsorption with Elution
recent advances
immunoadsorption apheresis
LDL apheresis
ELution commercial kits
NAT nucleic acid amplification technology Testing- Reverse transcription-poly...
ID-NAT (Individual donor nucleic acid testing)-
MP-NAT (mini-pool testing)-
window period
Reverse transcription-polymerase chain reaction (RT PCR)
Transcription mediated amplification (TMA)
automated triplex NAT assays
RT- PCR- Steps
TMA steps
RT PCR vs TMA difference
NAT for HIV Hepatitis B hepatitis C
New Emerging Pathogens in blood and blood components transfusion
Risk categories of emerging infections
dengue
HTLV I/II
Chickengunya
covid
corona virus
west nile virus
zika virus
ebola virus
cytomegalovirus
ebstein barr virus
parvovirus
bacteria
Yersinia
Pseudomonas
Staphylococcus epidermidis or Staphylococcus aureus-
Propionibacterium acnes
parasites- Babesia microti, Trypanosoma cruzi, and malaria (Plasmodium species).
pathogen inactivation of cellular components.pptx
Chemical inactivation
Photo-inactivation
Solvent-detergent Plasma
Photosensitizers
Methylene Blue light treatment
Psoralen Ultraviolet Light Treatment
Riboflavin Light Treatment
INTERCEPT System
Mirasol system
Platelet and plasma Pathogen Inactivation
FRALE and azridine compounds
1. Bio preservation of Red Cell Components 2. CULTURED RBCs 3. solvent plasma
1. Bio preservation of Red Cell Components
2. CULTURED RBCs
3. Solvent plasma
Hypothermic storage
Cryopreservation
Lyophilization
Desiccated RBCs
Three major sources of cells are under consideration:
circulating stem and progenitor cells from adults or from cord blood
immortalized progenitors
pluripotent stem cells.
Immortalized Progenitors
LIQUID CULTURE METHODS- by the SED (stem cell factor (SCF), erythropoietin, and dexamethasone) and STIF cocktails (stem cell factor, thombopoietin, insulin-like growth factor-2, fibroblast growth factor-2)
ENUCLEATION- separation of extruded nuclei from cRBCs
SCALING UP- using cord blood CD34+ cells in bioreactors
and treated for 4 h with TNBP (tri-nitrobutylphosphate)solvent and with Triton X-100 detergent
Storage of Blood Components- equipments, effects of improper storage, transpo...
Introduction
Equipments required
Harmful effects of improper storage
Storage of various blood components- AABB guidelines
NACO guidelines for storage
Storage during transport
Storage in frozen state
Physical and chemical changes in stored blood
Peripheral blood stem cell transplantation- sources mobilization preservation...
Human Stem Cells- Introduction
Types of HSC transplants
Indications
Sources of stem cells
Collection and mobilization
Types of Mobilizing agents
Processing
Cryopreservation and storage
PBSC Transplant
Quality control
Complications
DONOR RECRUITMENT AND RETENTION STRATEGIES.pptx
1. Categories of Blood Donors
2. Donor Recruitment Strategies
3. Donor Retention Strategies
4. Donor Education and motivation
5. Deterrents to Donation
6. Donor Selection and Counselling
7. Donor Deferral and Referral
8. NACO report
9. Donor records
Human platelet antigens- platelet specific antigens, platelet antigens on HLA...
1. Introduction
2. Human Platelet antigens
3. (HPAs) shared with other tissues
4. HLA Antigens
5. ABH Antigens
Others
6. Platelet Specific Antigens
7. Antigen nomenclature
8. Alloimmunization to Platelet Antigens
9. Clinical consequences of HPA alloantibody formation
10. Methods for detection
11. Platelet Selection and 12. prevention of alloimmunity
antigen and antibody reactions- Immunology
This seminar includes-
1. Characteristics of Antigens and Antibodies
2. Characteristics of Antigen-Antibody Reactions
3. Types of Antigen-Antibody Reactions
4. Factors affecting Antigen-Antibody reactions
5. Grading of reactions
6. Antiglobulin tests
7. Classification to immunodeficiency diseases
SEMINAR BASICS OF IMMUNOLOGY- Antigens antibodies immunoglobulins and comple...
The basics of Immunology consisting of -
1. BASIC DEFINITIONS
2. HISTORY OF IMMUNOLOGY
3. ANATOMY, PHYSIOLOGY & PATHOLOGY OF IMMUNOLOGY
4- TYPES OF IMMUNITY (including COMPLEMENT SYSTEM)
5- CELLS AND TISSUES OF IMMUNE SYSTEM
6-ANTIGENS AND ANTIBODIES
7- IMMUNOGLOBULINS
8- MHC AND CYTOKINES
NVBDCP.pptx Nation vector borne disease control program
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Physiology of Special Chemical Sensation of Taste
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
How to Give Better Lectures: Some Tips for Doctors
Talk given to Koronadal Internists Society, Marbel, South Cotabato as part of the Continuing Medical Education (CME) series.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
More Related Content
More from DrShinyKajal
Transfusion support in Surgery- elective surgery, cardiac surgery, MSBOS, Tra...
AABB indications
Elective surgeries- Maximum surgical blood ordering schedule
Anemia and surgery- including Transfusion Trigger
Surgery and coagulation disorders- including factor replacement
Transfusion in cardiac surgeries- including autologous transfusion
Patient Blood management in surgery
Allogenic Transfusion
Autologous Transfusion- Intra And Postoperative Red Cell Salvage, Haemodilution
Blood Substitutes
Haematopoietic Factors
Antifibrinolytics
Fibrin Sealants
Conjugated Oestrogens.
AABB pretransfusion testing schemes
Type and screen
Maximum surgical blood ordering schedule
transfusion trigger for surgery
factor replacement in surgery
autologous transfusion
cell salvage
perioperative
massive transfusion protocol
Platelet disorders- qualitative and quantitative
platelets
functions
functional qualitative platelet disorders
quantitative platelet disorders
thrombocytopenia
thrombocytosis
platelet adhesion
aggregation
glanzman thrombesthenia
bernard soulier syndrome
alpha granules
idiopathic thrombocytopenic purpura ITP
Thrombotic thrombocytopenic purpura TTP
Hemolytic uremic syndrome HUS
Neonatal Alloimmune Thrombocytopenia
PSEUDO Thrombocytopenia
vin willebrand factor, disease and Hemophilia
Pathophysiology & Management of-Haemophilia
Von Willebrand Disease
hemostatic pathway
coagulation pathway
hemophilia A
Hemophilia B
parahemophilia
clinical manifestations
treatments
inheritance
laboratory features
prenatal analysis
factor concentrates
eaca
tranexamic acid
DDVAPS- desmopressin agents
vWF gene
classifcation of vWD
Granulocyte antigens & antibodies and their role in transfusion medicinepptx
what are granulocytes?
Granulocyte antigens
neonatal alloimmune neutropenia (NAN)
Transfusion-related acute lung injury (TRALI)
immune neutropenia after HPC transplantation
refractoriness to granulocyte transfusion
chronic benign autoimmune neutropenia of infancy (AIN)
Antigens on FcyRIIIb (CD16b)
Antigens on CD177
Antigens on CTL2
Antigens on CD11a and CD11b
Immune neutrophil disorders
granulocyte agglutination tests
GRANULOCYTE IMMUNOFLUORESCENCE test
HNA typing
Monoclonal-antibody capture assays:
Adsorption and Elution- heal elution ether elution Autoadsorption alloadsorpt...
TYPES- ELUTION
Heat Elution
Ether Elution
Elution using chemical treatment
CDP
ZZAP
ELUTION APPLICATIONS
Autoadsorption
Alloadsorption
Allo-Antibody Adsorption Technique
Cold Auto-Adsorption Technique
Warm Auto-Adsorption Technique
Donath-Landsteiner Technique
Adsorption with Elution
recent advances
immunoadsorption apheresis
LDL apheresis
ELution commercial kits
NAT nucleic acid amplification technology Testing- Reverse transcription-poly...
ID-NAT (Individual donor nucleic acid testing)-
MP-NAT (mini-pool testing)-
window period
Reverse transcription-polymerase chain reaction (RT PCR)
Transcription mediated amplification (TMA)
automated triplex NAT assays
RT- PCR- Steps
TMA steps
RT PCR vs TMA difference
NAT for HIV Hepatitis B hepatitis C
New Emerging Pathogens in blood and blood components transfusion
Risk categories of emerging infections
dengue
HTLV I/II
Chickengunya
covid
corona virus
west nile virus
zika virus
ebola virus
cytomegalovirus
ebstein barr virus
parvovirus
bacteria
Yersinia
Pseudomonas
Staphylococcus epidermidis or Staphylococcus aureus-
Propionibacterium acnes
parasites- Babesia microti, Trypanosoma cruzi, and malaria (Plasmodium species).
pathogen inactivation of cellular components.pptx
Chemical inactivation
Photo-inactivation
Solvent-detergent Plasma
Photosensitizers
Methylene Blue light treatment
Psoralen Ultraviolet Light Treatment
Riboflavin Light Treatment
INTERCEPT System
Mirasol system
Platelet and plasma Pathogen Inactivation
FRALE and azridine compounds
1. Bio preservation of Red Cell Components 2. CULTURED RBCs 3. solvent plasma
1. Bio preservation of Red Cell Components
2. CULTURED RBCs
3. Solvent plasma
Hypothermic storage
Cryopreservation
Lyophilization
Desiccated RBCs
Three major sources of cells are under consideration:
circulating stem and progenitor cells from adults or from cord blood
immortalized progenitors
pluripotent stem cells.
Immortalized Progenitors
LIQUID CULTURE METHODS- by the SED (stem cell factor (SCF), erythropoietin, and dexamethasone) and STIF cocktails (stem cell factor, thombopoietin, insulin-like growth factor-2, fibroblast growth factor-2)
ENUCLEATION- separation of extruded nuclei from cRBCs
SCALING UP- using cord blood CD34+ cells in bioreactors
and treated for 4 h with TNBP (tri-nitrobutylphosphate)solvent and with Triton X-100 detergent
Storage of Blood Components- equipments, effects of improper storage, transpo...
Introduction
Equipments required
Harmful effects of improper storage
Storage of various blood components- AABB guidelines
NACO guidelines for storage
Storage during transport
Storage in frozen state
Physical and chemical changes in stored blood
Peripheral blood stem cell transplantation- sources mobilization preservation...
Human Stem Cells- Introduction
Types of HSC transplants
Indications
Sources of stem cells
Collection and mobilization
Types of Mobilizing agents
Processing
Cryopreservation and storage
PBSC Transplant
Quality control
Complications
DONOR RECRUITMENT AND RETENTION STRATEGIES.pptx
1. Categories of Blood Donors
2. Donor Recruitment Strategies
3. Donor Retention Strategies
4. Donor Education and motivation
5. Deterrents to Donation
6. Donor Selection and Counselling
7. Donor Deferral and Referral
8. NACO report
9. Donor records
Human platelet antigens- platelet specific antigens, platelet antigens on HLA...
1. Introduction
2. Human Platelet antigens
3. (HPAs) shared with other tissues
4. HLA Antigens
5. ABH Antigens
Others
6. Platelet Specific Antigens
7. Antigen nomenclature
8. Alloimmunization to Platelet Antigens
9. Clinical consequences of HPA alloantibody formation
10. Methods for detection
11. Platelet Selection and 12. prevention of alloimmunity
antigen and antibody reactions- Immunology
This seminar includes-
1. Characteristics of Antigens and Antibodies
2. Characteristics of Antigen-Antibody Reactions
3. Types of Antigen-Antibody Reactions
4. Factors affecting Antigen-Antibody reactions
5. Grading of reactions
6. Antiglobulin tests
7. Classification to immunodeficiency diseases
SEMINAR BASICS OF IMMUNOLOGY- Antigens antibodies immunoglobulins and comple...
The basics of Immunology consisting of -
1. BASIC DEFINITIONS
2. HISTORY OF IMMUNOLOGY
3. ANATOMY, PHYSIOLOGY & PATHOLOGY OF IMMUNOLOGY
4- TYPES OF IMMUNITY (including COMPLEMENT SYSTEM)
5- CELLS AND TISSUES OF IMMUNE SYSTEM
6-ANTIGENS AND ANTIBODIES
7- IMMUNOGLOBULINS
8- MHC AND CYTOKINES
More from DrShinyKajal (15)
Transfusion support in Surgery- elective surgery, cardiac surgery, MSBOS, Tra...
Transfusion support in Surgery- elective surgery, cardiac surgery, MSBOS, Tra...
Granulocyte antigens & antibodies and their role in transfusion medicinepptx
Granulocyte antigens & antibodies and their role in transfusion medicinepptx
Adsorption and Elution- heal elution ether elution Autoadsorption alloadsorpt...
Adsorption and Elution- heal elution ether elution Autoadsorption alloadsorpt...
NAT nucleic acid amplification technology Testing- Reverse transcription-poly...
NAT nucleic acid amplification technology Testing- Reverse transcription-poly...
New Emerging Pathogens in blood and blood components transfusion
New Emerging Pathogens in blood and blood components transfusion
1. Bio preservation of Red Cell Components 2. CULTURED RBCs 3. solvent plasma
1. Bio preservation of Red Cell Components 2. CULTURED RBCs 3. solvent plasma
Storage of Blood Components- equipments, effects of improper storage, transpo...
Storage of Blood Components- equipments, effects of improper storage, transpo...
Peripheral blood stem cell transplantation- sources mobilization preservation...
Peripheral blood stem cell transplantation- sources mobilization preservation...
Human platelet antigens- platelet specific antigens, platelet antigens on HLA...
Human platelet antigens- platelet specific antigens, platelet antigens on HLA...
SEMINAR BASICS OF IMMUNOLOGY- Antigens antibodies immunoglobulins and comple...
SEMINAR BASICS OF IMMUNOLOGY- Antigens antibodies immunoglobulins and comple...
Recently uploaded
NVBDCP.pptx Nation vector borne disease control program
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Physiology of Special Chemical Sensation of Taste
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
How to Give Better Lectures: Some Tips for Doctors
Talk given to Koronadal Internists Society, Marbel, South Cotabato as part of the Continuing Medical Education (CME) series.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Valuable Content of Human Anatomy and Physiology of Urinary system as per PCI Syllabus for Pharmacy and PharmD Students.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With 100% Satisfaction
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Recently uploaded (20)
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
- 1. ANTIBODY SCREENING and IDENTIFICATION Presented By: Dr. Shiny Moderator: Dr. Nidhi Bansal
- 13. Screening through 2-3 cells
- 18. 11 cell panel identification CASE 1
- 25. CASE 2
- 34. THANKYOU